Trade Summary

3 days ago, Stokes Frank, serving as CFO at Castle Biosciences Inc (CSTL), sold 7,000 shares at $27.44 per share, for a total transaction value of $192,073.00. Following this transaction, Stokes Frank now holds 66,086 shares of CSTL.

This sale represents a 10.00% decrease in Stokes Frank's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Castle Biosciences Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.